ArticleScientific reports2025
Development of an AI-based magnetic resonance imaging reading support program (AMP) for deep endometriosis diagnosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Uterine microbiome signatures associated with endometriosis.BMC biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diagnosis of endometriosis faces significant challenges including diagnostic delay and reliance on invasive procedures. Deep endometriosis (DE) poses additional difficulties in non-invasive diagnosis due to its subtle and complex imaging features. To address these challenges, we developed an AI-based MRI reading support program (AMP) designed to improve diagnostic accuracy and efficiency, with the primary endpoint of demonstrating its potential to enhance radiologists' reading sensitivity. AMP comprises the following three models: (1) a nnU-Net model for endometriotic nodular lesion (plaque) segmentation, (2) a radiomics-based LightGBM model for adhesion detection, and (3) a nnU-Net model for detection/quantification of ovarian endometriotic cysts (OECs). In cross-validation, AMP achieves mean Dice similarity coefficient of 0.293 for plaque segmentation and 0.580 for OEC segmentation. For adhesion detection, AMP shows high performance for uterine adhesions (F1 scores > 0.6). In a preliminary clinical utility study with three radiologists, AMP improved mean recall for plaque detection from 0.73 to 0.91 demonstrating AMP's ability to support radiologists in identifying subtle DE lesions and adhesions. Our findings show that AMP is a reliable non-invasive clinical diagnosis tool, that has the potential to minimize diagnostic delays and improve patient outcome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.